Virtu Financial’s scPharmaceuticals SCPH Stock Holding History

Virtu Financial’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,732	Closed	-$112K	–	2162
2025 Q3	$112K	Buy	19,732 +1,287	+7%	+$6.59K	0.01%	1026
2025 Q2	$70K	Buy	+18,445	New	+$57.3K	﹤0.01%	1087
2024 Q4	–	Sell	-10,105	Closed	-$46K	–	1994
2024 Q3	$46K	Buy	+10,105	New	+$48.9K	﹤0.01%	1025
2024 Q2	–	Sell	-17,895	Closed	-$90K	–	1815
2024 Q1	$90K	Buy	+17,895	New	+$100K	0.01%	940
2022 Q3	–	Sell	-10,999	Closed	-$53K	–	2176
2022 Q2	$53K	Buy	+10,999	New	+$54.4K	﹤0.01%	1112
2021 Q1	–	Sell	-36,378	Closed	-$192K	–	1976
2020 Q4	$192K	Buy	+36,378	New	+$285K	0.02%	877

Virtu Financial's SCPH Position: Q4 2025 in Review

Virtu Financial sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 19,732 shares — an estimated $112K sold.

Virtu Financial first reported a position in SCPH in Q4 2020 and held it in 6 quarters. The position peaked at $192K in Q4 2020. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Virtu Financial reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 19,732 scPharmaceuticals shares in Q4 2025, an estimated $112K.
Virtu Financial first reported a position in scPharmaceuticals in Q4 2020 and held it in 6 quarters.
Virtu Financial's scPharmaceuticals position peaked at $192K in Q4 2020.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.